| ELA3A |
CCKBR, CCKRB: Gastrin/cholecystokinin type B receptor |
GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
0.305 |
Evidence |
|
| GABRA5 |
GABRA5: Gamma-aminobutyric acid receptor subunit alpha-5 precursor |
GABRG3 |
GABRG3: Gamma-aminobutyric acid receptor subunit gamma-3 precursor |
0.305 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
GPR87 |
GPR87, GPR95, FKSG78: Probable G-protein coupled receptor 87 |
0.305 |
Evidence |
|
| GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
GPR20 |
GPR20: Probable G-protein coupled receptor 20 |
0.305 |
Evidence |
|
| GABRR2 |
GABRR2: Gamma-aminobutyric acid receptor subunit rho-2 precursor |
CHRNE |
CHRNE, ACHRE: Acetylcholine receptor subunit epsilon precursor |
0.305 |
Evidence |
|
| GABRR2 |
GABRR2: Gamma-aminobutyric acid receptor subunit rho-2 precursor |
GABRA5 |
GABRA5: Gamma-aminobutyric acid receptor subunit alpha-5 precursor |
0.305 |
Evidence |
|
| FPRL2 |
FPRL2, FPRH1: FMLP-related receptor II |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
0.305 |
Evidence |
|
| GLRA2 |
GLRA2: Glycine receptor subunit alpha-2 precursor |
CHRND |
CHRND, ACHRD: Acetylcholine receptor subunit delta precursor |
0.305 |
Evidence |
|
| GLRA2 |
GLRA2: Glycine receptor subunit alpha-2 precursor |
CHRNA5 |
NACHRA5, CHRNA5: Neuronal acetylcholine receptor subunit alpha-5 precursor |
0.305 |
Evidence |
|
| GLRA2 |
GLRA2: Glycine receptor subunit alpha-2 precursor |
GABRR1 |
IPI00027150 |
0.305 |
Evidence |
|
| GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
CYSLTR2 |
CYSLTR2, CYSLT2, PSEC0146, CYSLT2R: Cysteinyl leukotriene receptor 2 |
0.305 |
Evidence |
|
| CHRNB2 |
CHRNB2: Neuronal acetylcholine receptor subunit beta-2 precursor |
GABRA3 |
GABRA3: Gamma-aminobutyric acid receptor subunit alpha-3 precursor |
0.305 |
Evidence |
|
| KCNA6 |
KCNA6: Potassium voltage-gated channel subfamily A member 6 |
SCN11A |
SCN11A, PN5, SCN12A, SNS2: Sodium channel protein type 11 subunit alpha |
0.305 |
Evidence |
|
| KCNA6 |
KCNA6: Potassium voltage-gated channel subfamily A member 6 |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
0.305 |
Evidence |
|
| KCNA6 |
KCNA6: Potassium voltage-gated channel subfamily A member 6 |
TRPC7 |
TRPC7, TRP7: Short transient receptor potential channel 7 |
0.305 |
Evidence |
|
| KCNA6 |
KCNA6: Potassium voltage-gated channel subfamily A member 6 |
KCNF1 |
KCNF1: Potassium voltage-gated channel subfamily F member 1 |
0.305 |
Evidence |
|
| GNB3 |
GNB3: Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 |
RGS6 |
IPI00719243 |
0.305 |
Evidence |
|
| RNH1 |
RNH1, PRI, RNH: Ribonuclease inhibitor |
CARD4 |
NOD1, CARD4: Nucleotide-binding oligomerization domain-containing protein 1 |
0.305 |
Evidence |
|
| CYP19A1 |
CYP19A1, ARO1, CYAR, CYP19: Cytochrome P450 19A1 |
POR |
POR, CYPOR: NADPH--cytochrome P450 reductase |
0.305 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
MTNR1B |
MTNR1B: Melatonin receptor type 1B |
0.305 |
Evidence |
|
| CHRNB1 |
CHRNB1, ACHRB, CHRNB: Acetylcholine receptor subunit beta precursor |
CHRNA10 |
CHRNA10, NACHRA10: Neuronal acetylcholine receptor subunit alpha-10 precursor |
0.305 |
Evidence |
|
| CHRNB1 |
CHRNB1, ACHRB, CHRNB: Acetylcholine receptor subunit beta precursor |
CHRNA2 |
CHRNA2: Neuronal acetylcholine receptor subunit alpha-2 precursor |
0.305 |
Evidence |
|
| CHRNB1 |
CHRNB1, ACHRB, CHRNB: Acetylcholine receptor subunit beta precursor |
CHRND |
CHRND, ACHRD: Acetylcholine receptor subunit delta precursor |
0.305 |
Evidence |
|
| CHRNB1 |
CHRNB1, ACHRB, CHRNB: Acetylcholine receptor subunit beta precursor |
CHRNA7 |
CHRNA7, NACHRA7: Neuronal acetylcholine receptor subunit alpha-7 precursor |
0.305 |
Evidence |
|
| CHRNB1 |
CHRNB1, ACHRB, CHRNB: Acetylcholine receptor subunit beta precursor |
CHRNA5 |
NACHRA5, CHRNA5: Neuronal acetylcholine receptor subunit alpha-5 precursor |
0.305 |
Evidence |
|